- Ticker
- NVO
- Asset type
- Stocks
- Collections
Healthcare
Pharmaceuticals
Novo Nordisk
Novo-Nordisk A/S
Novo Nordisk is the global leading provider of diabetes care products, commanding roughly one-third of the branded diabetes treatment market. Based in Denmark, the company manufactures and markets various treatments for diabetes and obesity, including insulins and injectable therapies. Additionally, Novo Nordisk has a biopharmaceutical segment that focuses on protein therapies for disorders like hemophilia.
How to buy Novo Nordisk on Grow →
Trading hours
The following are when you can trade Novo Nordisk in Grow (24/5).
| Session | Hours (ET) | Tradeable |
|---|---|---|
| Pre-market | 4:00 AM–9:30 AM ET | |
| Regular | 9:30 AM–4:00 PM ET | |
| After-hours | 4:00 PM–8:00 PM ET | |
| Overnight | 8:00 PM–4:00 AM ET (next day) |
Excludes US market holidays.
Novo Nordisk is a tokenized asset that is backed 1:1 by the underlying security held at a licensed custodian. Learn more
